Parkon® in the treatment of multiple sclerosis. A pilot study

• 主要な著者: Goldstein NI (著者), Golubev VL (著者), Goldstein RN (著者)
• フォーマット: 図書
• 出版事項: Open Journal of Parkinson's Disease and Treatment - Peertechz Publications, 2020-08-07.
• 主題: Research Article
• オンライン･アクセス: Connect to this object online.

<p>Multiple Sclerosis (MS) is one of the most common chronic demyelinating diseases of the central nervous system. The disease affects and relatively quickly leads to disability in mainly people 15-40 years of age. The development of MS can occur progressively or with exacerbations and remissi...